Cabaletta Bio (CABA) Cash from Operations (2018 - 2025)

Cabaletta Bio's Cash from Operations history runs 8 years deep, the most recent figure standing at 35343000.0 for Q4 2025.

• In Q4 2025, Cash from Operations fell 52.85% year-over-year to 35343000.0; the TTM figure through Dec 2025 stood at 131080000.0 (down 48.58% YoY), while the FY2025 annual figure was 131080000.0, down 48.58% from the prior year.
• Cash from Operations for Q4 2025 stood at 35343000.0, down from 34509000.0 in the prior quarter.
• The five-year high for Cash from Operations was 6580000.0 in Q2 2021, with the low at 35343000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 12708500.0 (2022), against an average of 17667000.0.
• The sharpest annual moves came in 2021 and 2024: Cash from Operations rose 13.9% in 2021, then plunged 90.26% in 2024.
• Cabaletta Bio's Cash from Operations stood at 10515000.0 in 2021, then declined by 15.37% to 12131000.0 in 2022, then slumped by 35.59% to 16448000.0 in 2023, then sank by 40.58% to 23122000.0 in 2024, then tumbled by 52.85% to 35343000.0 in 2025.
• Business Quant data shows CABA's Cash from Operations at 35343000.0 in Q4 2025, 34509000.0 in Q3 2025, and 30426000.0 in Q2 2025.